Rare diseases
Investigational molecules
Locations
Kettegaard Alle 30, 2650 Hvidovre, Denmark
Region Hovedstaden in Hvidovre, Denmark specialises in clinical trials of conditions such as Obesity, Chronic obstructive pulmonary disease, Colitis ulcerative, Type 2 diabetes mellitus, and other specialisations. This site conducts important research.
Clinical trials currently enrolling participants at this site.
Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
DenmarkStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
DenmarkStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
DenmarkStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
DenmarkStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
DenmarkStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
DenmarkStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
DenmarkPhase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
DenmarkEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
DenmarkA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
DenmarkRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
DenmarkEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
DenmarkGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
